In February 2009, the Third National Audit Project of the Royal College of Anaesthetists (NAP3) published prospective data of the number of central neuraxial blocks (CNBs) performed annually in the UK National Health Service (NHS) and the incidence of associated major complications. 1 The census phase of the audit compiled data on more than 700 000 CNBs throughout the UK with the majority of CNBs performed in the obstetric (45%) and adult perioperative settings (44%). The results demonstrated a lower incidence of major complications due to CNB than previous smaller studies. The incidence of permanent harm differed markedly between the type of CNB and the clinical setting in which it was performed.
To aid the process of dissemination and implementation, NAP3 was disseminated as follows: † Executive summary of NAP3 sent to all UK NHS hospital Chief Executives. † Summary slide-set sent to each UK NHS hospital anaesthetic department and available for downloading on the RCoA website. † Presentation of results at launch and subsequently by a series of invited lectures.
This survey examines how effectively the NAP3 results had been disseminated to departments of anaesthesia, explores whether the results of NAP3 have changed practice in CNB, and examines anaesthetists' attitudes to different methods of dissemination.
Methods
The NAP3 project established a network of local reporters at 309 NHS hospitals. These local reporters were e-mailed 1 yr after the publication of NAP3 and asked to complete an electronic questionnaire which included tick-box responses and free text comment (available from the authors on request). The survey explored, and clearly differentiated between, personal and departmental practices. When the local reporter was not contactable, the survey was distributed to the anaesthetic department college tutor. Data were compiled, anonymized, and analysed using a Microsoft Excel spreadsheet (Microsoft Corporation, Reading, UK). As participation was voluntary, ethical approval was not sought for this study.
Results
The survey was sent to 288 local reporters (with responsibility for 309 hospitals' NAP3 returns). A total of 217 responses were received; a response rate of 75.3%. Regarding personal practice, 214 (99%) of respondents perform CNB (96% adult perioperative, 51% obstetric, 14% paediatric perioperative, 10% chronic pain management). With regard to dissemination of results, almost all responders (216/217: 99.5%) had heard of NAP3 and 212 (97.7%) were aware of the results. The most common methods by which respondents learned of the NAP3 results were reading the original article in the BJA, departmental presentation, and reading the original report ( Table 1 ). The cumulative methods in which respondents were informed of the results add up to 575, implying that respondents were informed of the results approximately 2.7 times per respondent. The NAP3 results were reported in 174 (80.2%) of respondents' hospitals.
Overall, 178 (82%) of respondents judged that the NAP4 results were disseminated satisfactorily. Approximately half of the respondents (50.2%) reported that dissemination could not be improved. Suggestions for improving dissemination were e-mail to all college members (40 respondents), presentation of summary results (22), presentation at governance meeting (20), article in College Bulletin (19), and hospital guideline (50).
Half of the respondents indicated that NAP3 had led to changes in departmental practice in their hospital, with the most frequent reported change being in the information provided to patients before CNB ( Fig. 1) . In many hospitals, this included development of a patient information leaflet describing the revised risks of CNB and information on signs and symptoms of potential complications. Approximately 20 -28% had also changed their management of CNB, nursing monitoring of CNB, or investigation of potential complications. Two-thirds of respondents had changed the information they personally provided to patients before performing CNB. Approximately 16-25% had also changed their management of CNB or investigation of potential complications (Fig. 2) .
One hundred and ninety-four (89%) respondents reported no change in the overall use of CNB in their department. Twenty (9.2%) respondents reported a reduction in the number of CNB performed and three (1.4%) reported an increase.
One hundred and eighty-five respondents (85.3%) reported that the frequency with which they personally perform CNB had not changed since the publication of NAP3. Twenty-nine (13.4%) respondents had decreased their use of CNB, while three (1.4%) respondents had increased CNB use.
The final question of the survey asked 'Which do you consider to have more effect in changing practice: learning points or recommendations?' Approximately two-thirds of respondents (70.5%) considered both to be equally effective with 15.7% preferring recommendations and 13.8% preferring learning points.
Discussion
On completion of any research project, an important task is to ensure effective dissemination of results. Dissemination aims to ensure awareness of research findings in the relevant target audiences. Effective dissemination enables re-appraisal of current practice and may facilitate appropriate change by individuals and organizations. 2 This survey
shows that the results of NAP3 have been disseminated adequately throughout the UK. Almost all anaesthetic One year on from NAP3
BJA departments and individual respondents (largely local reporters) were aware of the results of the project and the results had been specifically presented in 80% of departments. It appears likely that most anaesthetists will have had exposure to the results of NAP3 more than once in the first year after publication. Our response rate of 75% was similar to other surveys or questionnaires reviewing the effect of new guidelines and audits on practice.
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The most widespread change in practice after publication of NAP3 has been to alter the information provided to patients who receive CNB: this change affected 50% of departments and 65% of individual respondents. This is reassuring, as a primary aim of NAP3 was to acquire more accurate estimates of the major risks of CNB with the express intention that this would improve information for patients and anaesthetists alike. A majority of respondents stated that NAP3 has enabled them to provide more accurate statements about risk when consenting patients. A smaller, but still substantial, number of departments (and individuals) reported changes to other elements of their practice, varying between one in three and one in six departments.
The predominant finding of NAP3 was that the incidence of major complications of CNB (permanent patient harm) was lower than reported in several recent smaller studies. The effect of NAP3 on departmental (and personal) use of CNB is therefore relevant. While most departments and individuals have not changed the frequency of use since NAP3, where such change has taken place, this generally has been a reduction in the frequency of CNB use. Based on individual respondents' comments, the changes most frequently referred to the use of perioperative epidurals, but also involve an alteration in patient selection for CNB and a decrease in the use of combined spinal-epidurals. There are several reasons why this may have occurred. First, NAP3 was a project exclusively describing major complications (rather than benefits) of CNB and this in itself may have led to a reduction in use. Secondly, the area of clinical practice identified by NAP3 as of highest risk of major complications was perioperative epidurals. However, factors external to NAP3 may also have led to a reduction in the use of CNB. These include: increased emphasis on enhanced recovery and early mobilization, increased interest in alternatives to CNB (e.g. transversus abdominus plane and paravertebral block), and the introduction of new longer-acting anti-coagulants for thromboprophylaxis which may increase concerns about the concurrent use of perioperative epidurals. Of note, a trend of reduced use of perioperative epidurals was already evident before the publication of NAP3, but we cannot determine whether NAP3 has slowed this trend. 5 -7 A survey in a single hospital 8 at 6 months after the publication of NAP3 reported that only 60% of responders were aware of the results of NAP3, compared with 99.5% of local reporters who responded to our survey 1 yr after publication. While it is likely that substantial differences exist because of the population we surveyed, the differences may also reflect local failure of dissemination or that in the intervening 6 months, a wider awareness of the data has been achieved. There were several suggestions from the survey for improved dissemination of the results. Most of these suggestions had or have already been implemented. The most common suggestion (e-mailing individual members of the RCoA) is not currently practicable but should be considered for future projects. One comment made by several respondents was that the numbers generated by the project were difficult to remember. In response to this, a table summarizing the most frequently requested point estimates for risk has been added to the College website and is reproduced here ( Table 2 ). The results have now also been made available as a freely downloadable application ('app') for i-phone users.
A lay member of the NAP4 panel had commented 'Learning points are for clinicians to read and ignore, recommendations are for organisations to implement'. In this survey, the respondents expressed equal preference for learning points and recommendations. There is an argument that clear recommendations made by organizations with authority may be more likely to promote change and subsequent audit of that change. A systematic review assessing the effectiveness of guideline recommendations showed a lower compliance with recommendations that were deemed complex. 9 The NAP3 report described learning points while the recently published NAP4 report 10 11 uses a combination of learning points (for information dissemination) and recommendations (to describe desired changes in practice).
There are several limitations to this survey. First, our 75% response rate means that we have not sampled the opinions of a quarter of UK departments of anaesthesia. More importantly, we have surveyed local reporters who may be a self-selected group and therefore not representative. Our prime aim was to identify changes in departmental policy regarding CNB and we judged that local reporters would be at least as likely as other anaesthetists to be aware of such changes as a result of the NAP3 project and probably most likely to respond to this survey. By contacting local reporters, it is likely we have therefore achieved a higher response rate than a random selection of anaesthetists would have achieved. This group will certainly have had an unusually high awareness of NAP3 but we can only speculate whether they would be more likely than an unselected group to have altered their practice in response to the results of NAP3. Finally, as the survey was performed only 1 yr after publication of NAP3, it is possible that increases in awareness and changes in practice are still occurring, if so this survey will under-estimate the overall effect of the project.
In conclusion, this survey demonstrates that the results of NAP3 have been disseminated to the vast majority of anaesthetic departments in the country of publication. NAP3 has led to changes in practice in the majority of hospitals, most notably in influencing the departmental information provided to patients during consent for CNB. There is evidence that it has provided anaesthetists with more accurate information on risk, enabling better risk:benefit assessments and leading to changes in practice. Based only on the response of local reporters, it also seems likely that individual anaesthetists' practices have changed similarly. As a result of this survey, new modes of dissemination have been made available. 
